Edwards Lifesciences (EW) Notes Payables (2009 - 2014)

Edwards Lifesciences has reported Notes Payables for 4 years, with the latest figure at $2.6 million in Q4 2014.

• On a quarterly basis, Notes Payables fell 80.15% year-over-year to $2.6 million in Q4 2014; TTM through Dec 2014 was $2.6 million, a 80.15% decrease from a year earlier, with the FY2014 full-year figure at $2.6 million, down 80.15% from the prior year.
• Notes Payables was $2.6 million for Q4 2014 at Edwards Lifesciences, up from $2.2 million in the prior quarter.
• The five-year high for Notes Payables was $14.7 million in Q4 2010, with the low at $2.2 million in Q3 2014.
• Average Notes Payables over 3 years is $8.2 million, with a median of $7.8 million recorded in 2013.
• The sharpest annual moves came in 2010 and 2014: Notes Payables surged 390.0% in 2010, then slumped 80.15% in 2014.
• Over 3 years, Notes Payables stood at $14.7 million in 2010, then dropped by 10.88% to $13.1 million in 2013, then plunged by 80.15% to $2.6 million in 2014.
• The last three Notes Payables figures came in at $2.6 million (Q4 2014), $2.2 million (Q3 2014), and $13.1 million (Q4 2013), per Business Quant data.